Moreover, RBPs such as SRSF1 have been shown to be a direct target of oncogenes, providing a scenario whereby oncogenic activation of these splicing factors may lead to far-reaching alterations in splicing profiles across cancer types (33). The gene discussed is SRSF1; the disease is cancer.